| scholarly article | Q13442814 |
| P2093 | author name string | George P Allen | |
| Kayla A Harris | |||
| P2860 | cites work | Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus | Q28343420 |
| Selection of resistant bacteria at very low antibiotic concentrations | Q28479239 | ||
| Practice guidelines for the management of infectious diarrhea | Q30306770 | ||
| Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. | Q33981343 | ||
| Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials | Q34235318 | ||
| Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies | Q34347864 | ||
| Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China | Q34501014 | ||
| Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections | Q34621459 | ||
| In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model | Q34788573 | ||
| Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study | Q35621105 | ||
| In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis | Q36313268 | ||
| Mutant selection window hypothesis updated. | Q36728061 | ||
| Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model | Q36976649 | ||
| Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model | Q37274635 | ||
| Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments | Q37624733 | ||
| Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline | Q37631945 | ||
| Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy. | Q37733449 | ||
| β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review | Q38004063 | ||
| Global burden of childhood diarrhea and interventions | Q38237675 | ||
| Treatment of drug-resistant Shigella infections | Q38268512 | ||
| Long-term comparison of antibiotic resistance in Vibrio cholerae O1 and Shigella species between urban and rural Bangladesh | Q38697390 | ||
| Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011 | Q39358918 | ||
| In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. | Q39746394 | ||
| Notes from the field: emergence of Shigella flexneri 2a resistant to ceftriaxone and ciprofloxacin --- South Carolina, October 2010. | Q40340615 | ||
| Preliminary incidence and trends of infection with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2014. | Q40939672 | ||
| Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin | Q41648730 | ||
| Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. | Q41696128 | ||
| Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae | Q41785898 | ||
| Emergence of resistance to third-generation cephalosporin in Shigella--a case report | Q43231792 | ||
| Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States | Q43233541 | ||
| Magnitude of drug resistant Shigellosis: a report from Bangalore | Q43279809 | ||
| Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model | Q43988363 | ||
| Rapid emergence of third-generation cephalosporin resistance in Shigella sp. isolated in Andaman and Nicobar Islands, India | Q44784321 | ||
| In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants. | Q45022845 | ||
| Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits. | Q45066135 | ||
| Spontaneous mutation frequency and molecular mechanisms of Shigella flexneri fluoroquinolone resistance under antibiotic selective stress | Q46791844 | ||
| The mutant selection window in rabbits infected with Staphylococcus aureus. | Q51109317 | ||
| Predicting bacterial resistance using the time inside the mutant selection window: possibilities and limitations. | Q54281714 | ||
| Dose-related selection of fluoroquinolone-resistant Escherichia coli. | Q54437857 | ||
| Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration. | Q54466642 | ||
| Rapid emergence of third generation cephalosporin resistant Shigella spp. in Southern Vietnam | Q56875735 | ||
| New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach | Q83008539 | ||
| Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin | Q84585747 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Shigella flexneri | Q1644417 |
| azithromycin | Q165399 | ||
| ceftriaxone | Q421713 | ||
| levofloxacin | Q424193 | ||
| P577 | publication date | 2017-06-27 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | In Vitro Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin | |
| P478 | volume | 61 |
| Q64238157 | Mutations in play an important role in ciprofloxacin-resistant | cites work | P2860 |
Search more.